Primary objective
To evaluate the efficacy and safety of pharmacological interventions for the management of nocturnal problems in PD.
Secondary objectives
To address the spectrum of pharmacological strategies proposed for the treatment of sleep problems in PD.
To address the methodological quality of trials investigating the treatment of sleep problems in PD.